Not applicableUnknownNCT04280133What this trial is testingCAR T-CELL Therapy Educational Video TrialWho this might be right forHematologic MalignancyCAR-T Cell Therapy Massachusetts General Hospital 80
Not applicableStudy completedNCT00996047What this trial is testingS9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms SWOG Cancer Research Network 3,341
Testing effectiveness (Phase 2)UnknownNCT03258047What this trial is testingNovel Autologou CAR-T Therapy for Relapsed/Refractory B Cell LymphomaWho this might be right forB Cell Lymphoma First Affiliated Hospital of Zhejiang University 60
Testing effectiveness (Phase 2)Looking for participantsNCT05745714What this trial is testingHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWho this might be right forAcute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more Princess Maxima Center for Pediatric Oncology
Testing effectiveness (Phase 2)Study completedNCT01477749What this trial is testingSipuleucel-T Manufacturing Demonstration StudyWho this might be right forCancer of ProstateCancer of the ProstateNeoplasms, Prostate+4 more Dendreon 47
Testing effectiveness (Phase 2)Study completedNCT00337987What this trial is testingA Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell LymphomaWho this might be right forPeripheral T-Cell Lymphoma Yale University 49
Testing effectiveness (Phase 2)Study completedNCT06865352What this trial is testingSafety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell TransplantationWho this might be right forAcute Lymphoblastic Leukemia ALLAcute Myeloid Leukemia (AML) Fondazione IRCCS Policlinico San Matteo di Pavia 15
Very early researchStudy completedNCT04890236What this trial is testingDuvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS StudyWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma Emory University 4
Very early researchNot Yet RecruitingNCT06986434What this trial is testingCAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic DifferentiationWho this might be right forRelapsed or Refractory Plasma Cell NeoplasmsLymphomas/Leukemias With Plasmacytic Differentiation Affiliated Hospital to Academy of Military Medical Sciences 20
Testing effectiveness (Phase 2)Study completedNCT04763616What this trial is testingStudy of Isatuximab and Cemiplimab in Relapsed or Refractory Natural Killer/T-cell Lymphoid MalignancyWho this might be right forNatural Killer/T-cell LymphomaRelapsed Natural Killer/T-cell LymphomaRefractory Natural Killer/T-cell Lymphoma Won Seog Kim 37
Very early researchNot Yet RecruitingNCT06786299What this trial is testingClinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.Who this might be right forRelapsed/Refractory Acute Myeloid Leukemia(AML) First Affiliated Hospital of Zhejiang University 18
Large-scale testing (Phase 3)Looking for participantsNCT07203352What this trial is testingEfficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALLWho this might be right forAcute Lymphoblastic Leukemia Nanfang Hospital, Southern Medical University 154
Early research (Phase 1)UnknownNCT05123209What this trial is testingSafety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver TumorsWho this might be right forLiver Cancer Beijing Immunochina Medical Science & Technology Co., Ltd. 12
Not applicableActive Not RecruitingNCT06362148What this trial is testingCirculating Tumor DNA in Peripheral T-cell LymphomasWho this might be right forPeripheral T-cell LymphomaNK/T-Cell Lymphoma University of Aarhus 50
Early research (Phase 1)Not Yet RecruitingNCT07841002What this trial is testingCLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML) Liping Dou 12
Testing effectiveness (Phase 2)Ended earlyNCT00589602What this trial is testingT-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more The Cleveland Clinic 13
Early research (Phase 1)Ended earlyNCT01644253What this trial is testingPhase 1b Safety and Efficacy Study of TRU-016Who this might be right forChronic Lymphocytic LeukemiaPeripheral T-cell Lymphoma Aptevo Therapeutics 87
Testing effectiveness (Phase 2)Looking for participantsNCT03587844What this trial is testingDosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome PatientsWho this might be right forMycosis FungoidesLymphomatoid PapulosisSezary Syndrome Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)Ended earlyNCT01625260What this trial is testingALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder CancerWho this might be right forNon-muscle Invasive Bladder Cancer Altor BioScience 12
Early research (Phase 1)Study completedNCT00002946What this trial is testingPenclomedine in Treating Patients With Solid Tumors or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 30